CLINICAL STUDY: CARDIOMYOPATHY
Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy
Shigekazu Fujioka, MDa,b,
Yasushi Kitaura, MDa,
Akira Ukimura, MDa,
Hirofumi Deguchi, MDa,
Keishiro Kawamura, MDa,
Tadashi Isomura, MDc,
Hisayoshi Suma, MDc and
Akira Shimizu, MDb
a Third Division, Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan
b Central Clinical Laboratory, Osaka Medical College, Takatsuki, Japan
c Shonan Kamakura General Hospital, Heart Center, Kamakura, Japan
Manuscript received January 13, 2000;
revised manuscript received May 4, 2000,
accepted June 28, 2000.
Reprint requests and correspondence: Dr. Shigekazu Fujioka, Third Division, Department of Internal Medicine, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki, 569-8686 Japan
OBJECTIVES
The aim of this study was to evaluate the viral etiology of idiopathic dilated cardiomyopathy (DCM).
BACKGROUND
The demonstration of enteroviral genome in hearts with DCM has reinforced the importance of enteroviruses in the pathogenesis of DCM. However, there is uncertainty about the character and activity of enteroviruses detected in the myocardium. Recently, the association of hepatitis C virus or adenovirus with DCM has been reported.
METHODS
Myocardial specimens from 26 patients with idiopathic DCM, which were obtained at partial left ventriculectomy (PLV), were examined virologically. Strand-specific detection of enteroviral RNA was performed to differentiate active viral replication from latent persistence. Polymerase chain reaction was used to detect genomic sequences of hepatitis C virus, adenovirus, cytomegalovirus, influenza viruses, mumps virus, herpes simplex viruses, varicella-zoster virus and Epstein-Barr virus.
RESULTS
Plus-strand enteroviral RNA was detected in 9 (35%) of the 26 patients. Minus-strand enteroviral RNA was determined in seven (78%) of these nine plus-strand RNA-positive patients. Sequence analysis revealed that the enteroviruses detected were coxsackie B viruses, such as coxsackievirus B3 and B4. However, genetic material from other viruses was not detected. Six (86%) of seven minus-strand enteroviral RNA-positive patients died of cardiac insufficiency within the first six months after PLV.
CONCLUSIONS
Coxsackie B viruses were seen in hearts with idiopathic DCM. Active viral RNA replication appeared to be present in a significant proportion of these cases. Minus-strand coxsackieviral RNA in the myocardium can be a marker for poor clinical outcome after PLV. There was no evidence of persistent infection by other viruses in hearts with DCM.
|
Abbreviations and Acronyms
| | cDNA | = complementary DNA | | DCM | = dilated cardiomyopathy | | N-PCR | = nested polymerase chain reaction | | NYHA | = New York Heart Association | | PCR | = polymerase chain reaction | | PLV | = partial left ventriculectomy | | RT-PCR | = reverse transcription polymerase chain reaction |
|
This article has been cited by other articles:

|
 |

|
 |
 
O. M. Hess, W. McKenna, and H.-P. Schultheiss
CHAPTER 18 Myocardial Disease
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dennert, H. J. Crijns, and S. Heymans
Acute viral myocarditis
Eur. Heart J.,
September 1, 2008;
29(17):
2073 - 2082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Uhl
Viral Myocarditis in Children
Crit. Care Nurse,
February 1, 2008;
28(1):
42 - 63.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L.P. Caforio, F. Calabrese, A. Angelini, F. Tona, A. Vinci, S. Bottaro, A. Ramondo, E. Carturan, S. Iliceto, G. Thiene, et al.
A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis
Eur. Heart J.,
June 1, 2007;
28(11):
1326 - 1333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kobayashi-Miura, K. Shioji, Y. Hoshino, H. Masutani, H. Nakamura, and J. Yodoi
Oxygen sensing and redox signaling: the role of thioredoxin in embryonic development and cardiac diseases
Am J Physiol Heart Circ Physiol,
May 1, 2007;
292(5):
H2040 - H2050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Fujinami, M. G. von Herrath, U. Christen, and J. L. Whitton
Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease
Clin. Microbiol. Rev.,
January 1, 2006;
19(1):
80 - 94.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W Mason
Myocarditis and dilated cardiomyopathy: An inflammatory link
Cardiovasc Res,
October 15, 2003;
60(1):
5 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Calabrese and G. Thiene
Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects
Cardiovasc Res,
October 15, 2003;
60(1):
11 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Baboonian and W. McKenna
Eradication of viral myocarditis: Is there hope?
J. Am. Coll. Cardiol.,
August 6, 2003;
42(3):
473 - 476.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Kuhl, M. Pauschinger, P. L. Schwimmbeck, B. Seeberg, C. Lober, M. Noutsias, W. Poller, and H.-P. Schultheiss
Interferon-{beta} Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction
Circulation,
June 10, 2003;
107(22):
2793 - 2798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Lynch, L. Wagoner, S. Li, L. Sparks, J. Molkentin, and G. W. Dorn II
Novel and nondetected human signaling protein polymorphisms
Physiol Genomics,
September 3, 2002;
10(3):
159 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Afanasyeva and N. R. Rose
Cardiomyopathy Is Linked to Complement Activation
Am. J. Pathol.,
August 1, 2002;
161(2):
351 - 357.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. Liu and J. W. Mason
Advances in the Understanding of Myocarditis
Circulation,
August 28, 2001;
104(9):
1076 - 1082.
[Full Text]
[PDF]
|
 |
|
|